Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03816163
Brief Title: A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

First Submitted : January 23, 2019
First Submitted that Met QC Criteria : January 23, 2019
First Posted : January 25, 2019

Last Update Submitted that Met QC Criteria : May 26, 2022
Last Update Posted : May 27, 2022